“High-Frequency Migraine Refractory to Usual Pharmacological Treatment and Antibody and Responsive to Full-Spectrum Cannabidiol: A Case Report”. Headache Medicine, vol. 13, no. 3, Sept. 2022, pp. 229-32, https://doi.org/10.48208/HeadacheMed.2022.26.